肺癌的辅助治疗。
Adjuvant treatment in lung cancer.
作者信息
Valladares Begoña Taboada, Crespo Patricia Calvo, Herranz Urbano Anido, Caamaño Antonio Gómez
机构信息
Department of Radiation Oncology, Hospital Universitario Santiago de Compostela. Tr Choupana S/N, 15706 Santiago de Compostela, Spain.
Department of Medical Oncology, Hospital Universitario Santiago de Compostela. Tr Choupana S/N, 15706 Santiago de Compostela, Spain.
出版信息
J Clin Transl Res. 2021 Apr 16;7(2):175-184. eCollection 2021 Apr 22.
BACKGROUND
Adjuvant treatment for both small-cell and non-small-cell lung cancer is a controversial topic. There are no published results from prospective studies that either confirm or reject the benefit of adjuvant radiotherapy, although the presentation of recent studies at a number of conferences questions whether there should be a change in the paradigm of adjuvant RT for lung cancer.
AIM
The main goal of this study is to review the most relevant publications on the topic, updating the state of the matter regarding adjuvant radiotherapy following lung surgery, and analyzing the role of chemotherapy in the process.
RELEVANCE FOR PATIENTS
This review aims to assess the potential benefit of PORT in NSCLC and SCLC patients by looking at recent research. In doing so, it will be possible to determine which patients might benefit from it as adjuvant treatment after pulmonary resection.
背景
小细胞肺癌和非小细胞肺癌的辅助治疗是一个有争议的话题。尽管近期一些会议上公布的研究对肺癌辅助放疗的模式是否应改变提出了质疑，但尚无前瞻性研究的结果能证实或否定辅助放疗的益处。
目的
本研究的主要目的是回顾该主题最相关的出版物，更新肺切除术后辅助放疗的现状，并分析化疗在此过程中的作用。
对患者的意义
本综述旨在通过研究近期的研究来评估术后放疗在非小细胞肺癌和小细胞肺癌患者中的潜在益处。这样做将有可能确定哪些患者在肺切除术后作为辅助治疗可能从中受益。
Zotero 插件